期刊文献+

B7-H3和B7-H4在鼻咽癌组织中的表达及意义 被引量:2

Expression and Clinical Significance of B7-H3 and B7-H4 in Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的探讨B7-H3和B7-H4基因突变在鼻咽癌中的表达及临床意义。方法以60例鼻咽癌标本作为病例组,以30例正常子鼻咽部组织作为对照组,应用免疫组织化学技术,检测两组中B7-H3和B7-H4的表达。结果 B7-H3和B7-H4在鼻咽癌组织中阳性率均明显高于正常鼻咽组织,差异均有显著统计学意义(P<0.01);Ⅲ+Ⅳ期及淋巴结转移患者B7-H3和B7-H4阳性率分别明显高于Ⅰ+Ⅱ期、无淋巴结转移患者,差异有明显的统计学意义(P<0.05)。结论 B7-H3和B7-H4与鼻咽癌发生和发展密切相关。 Objective To study the expression and clinical significance of B7-H3 and B7-H4 in nasopharyngeal carcinoma. Methods 60 cases of endometrial carcinoma was the case group,and 70 cases of normal endometrial was the control group.The expressions of B7-H3 and B7-H4 in the 2 groups were analyzed by immunohistochemisty. Results The positive rates of B7-H3 and B7-H4 in nasopharyngeal carcinoma were significantly higher than those of normal nasopharyngeal tissues,the differences were statistically significant( P < 0. 01); positive rates of B7-H3 and B7-H4 in stage Ⅲ and Ⅳ and lymph node metastasis patients were significantly higher than those of stage Ⅰ and Ⅱ and without lymph node metastasis patients,the differences were statistically significant( P < 0. 05). Conclusion B7-H3 and B7-H4 are closely related with the carcinogenesis and progression of nasopharyngeal carcinoma.
出处 《实用癌症杂志》 2014年第6期617-619,共3页 The Practical Journal of Cancer
基金 广东省科技计划项目(编号:2012B031800480)
关键词 B7-H3基因 B7-H4基因 鼻咽癌 B7-H3 gene B7-H4 gene Nasopharyngeal carcinoma
  • 相关文献

同被引文献31

  • 1Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion [ J ]. Science, 2011, 331(624) : 1565-1570. DOI: 10. l126/science. 1203486.
  • 2Chang CS, Chang JH, Hsu NC, et al costimulatory molecules are potential nasopharyngeal carcinoma [ J ]. BMC 10.1186/1471-2407-7-88. Expression of CDS0 and CD86 markers for better survival in Cancer, 2007, 7: 88. DOI:.
  • 3Ren SP, Wang L, Wang H, et al. Gene therapy for human nasopha-ryngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model [ J ]. Cancer Biother Radiopharm, 2008, 23 (5): 591-602. DOI: 10. 1089/ebr. 2007. 0447.
  • 4Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-13 targe- ted cancer therapy[J]. Int J Biol Sci, 2012, 8(7) : 964-978. DOI: 10.7150/ijbs. 4564.
  • 5Hu S, Zhou G, Zhang L, et al. The effects of functional polymor- phisms in the TGF[31 gene on nasopharyngeal carcinoma susceptibili- ty[ J ]. Otolaryngol Head Neck Surg, 2012, 146 (4) : 579-584. DOI : 10.1177/0194599811434890.
  • 6Poh YW, Gan SY, Tan EL. Effects of IL-6, IL-10 and TGF-[3 on the expression of survivin and apoptosis in nasopharyngeal carcinoma TW01 cells[J]. Exp Oncol, 2012, 34(2) : 85-89.
  • 7Flies DB, Sandier BJ, Sznol M, et al. Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy[ J ]. Yale J Biol Med, 2011, 84 (4) : 409-421.
  • 8Chen B J, Chapuy B, Ouyang J, et al. PD-L1 expression is charac- teristic of a subset of aggressive B-cell lymphomas and virus-associa- ted malignancies [ J]. Clin Cancer Res, 2013, 19 ( 13 ) : 3462- 3473. DOI: 10. 1158/1078-0432. CCR-13-0855.
  • 9Seliger B, Quandt D. The expression, function, and clinical rele- vance of B7 family members in cancer[ J]. Cancer Immunol Immu- nother, 2012, 61 (8): 1327-1341. DOI: 10. 1007/s00262-012- 1293-6.
  • 10Loos M, Hedderich DM, Friess H, et al. B7-h3 and its role in anti-.tumor immunity[ J]. Clin Dev Immunol, 2010: 683875. DOI: 10. 1155/2010/683875.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部